Australia Medical Device Contract Manufacturing Market Size 2024
USD 1,287.68 Million
Australia Medical Device Contract Manufacturing Market, CAGR
12.04%
Australia Medical Device Contract Manufacturing Market Size 2032
USD 3,197.31 Million
Market Overview
Australia Medical Device Contract Manufacturing Market size was valued at USD 1,287.68 million in 2024 and is anticipated to reach USD 3,197.31 million by 2032, at a CAGR of 12.04% during the forecast period (2024-2032).
The Australia Medical Device Contract Manufacturing market is driven by several key factors, including the increasing demand for advanced medical technologies, a growing aging population, and a rising prevalence of chronic diseases. These trends are pushing healthcare providers to adopt innovative devices, creating significant opportunities for contract manufacturers. Additionally, the market benefits from technological advancements such as 3D printing, automation, and enhanced materials, which streamline production processes and improve product quality. The rising focus on cost-effective healthcare solutions has led to greater outsourcing of manufacturing services, further fueling market growth. Additionally, the supportive regulatory environment and ongoing investments in healthcare infrastructure contribute to the industry’s expansion. As healthcare systems continue to modernize, there is a marked trend toward partnerships between device developers and contract manufacturers, ensuring faster time-to-market and optimized production capabilities for complex medical devices. These factors together create a robust foundation for sustained growth in the sector.
The geographical landscape of the Australia Medical Device Contract Manufacturing market is shaped by key regions such as New South Wales, Victoria, Queensland, Western Australia, and South Australia, each contributing uniquely to the industry through established healthcare infrastructure, innovation hubs, and skilled labor forces. New South Wales and Victoria, in particular, serve as major centers for research, development, and manufacturing activities due to their robust medical technology ecosystems. The market features a mix of leading domestic and global players that drive competition and innovation. Key players in the space include ResMed, Cochlear Limited, Freudenberg Medical, Osmosis Medical, and CSL Limited. These companies are known for their strong product portfolios, advanced manufacturing capabilities, and strategic partnerships across the healthcare value chain. Their presence not only strengthens the industry but also supports the broader goal of delivering high-quality, compliant, and technologically advanced medical devices to meet growing domestic and international demand.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research!
The Australia Medical Device Contract Manufacturing market was valued at USD 1,287.68 million in 2024 and is projected to reach USD 3,197.31 million by 2032, growing at a CAGR of 12.04%.
The global medical device contract manufacturing market was valued at USD 79,181.52 million in 2024 and is expected to reach USD 1,90,413.88 million by 2032, growing at a CAGR of 11.59% during the forecast period (2024-2032).
Increasing demand for cost-efficient, high-quality medical devices is a primary driver of market growth.
The adoption of advanced technologies like AI, IoT, and 3D printing is reshaping the contract manufacturing landscape.
The market is highly competitive, with major players such as ResMed, Cochlear Limited, and CSL Limited leading through innovation and strategic partnerships.
Regulatory complexities and stringent compliance requirements pose challenges to new entrants and small-scale manufacturers.
Geographically, New South Wales and Victoria are the leading hubs for medical device manufacturing due to strong infrastructure and R&D facilities.
A growing emphasis on sustainability and expansion into emerging global markets offer new growth opportunities for Australian contract manufacturers.
Report Scope
This report segments the Australia Medical Device Contract Manufacturing Market as follows:
Market Drivers
Growing Demand for Advanced Medical Devices
The demand for advanced medical devices is one of the primary drivers of the Australian Medical Device Contract Manufacturing market. For instance, Australia’s medical equipment industry has seen a surge in demand for innovative devices, particularly in response to public health needs. Technological advancements in healthcare, such as minimally invasive surgeries, wearable health monitors, and robotic-assisted procedures, have revolutionized the way medical treatments are administered. These manufacturers provide expertise in producing high-quality, precision medical devices at scale, meeting the growing demand for sophisticated products across various therapeutic areas, including cardiology, orthopedics, and diagnostics. This trend is expected to continue, as the push for more advanced medical technology accelerates globally.
Rising Prevalence of Chronic Diseases and Aging Population
Australia’s aging population is a critical factor driving the growth of the medical device sector. As the number of elderly individuals increases, there is a corresponding rise in age-related diseases such as diabetes, cardiovascular conditions, and arthritis, which require specialized medical devices. Additionally, chronic disease management, such as diabetes monitoring and cardiovascular care, is increasingly dependent on technological solutions like home diagnostic devices and implantable devices. The growing prevalence of these conditions necessitates the rapid development and manufacturing of medical devices that can address these healthcare challenges. Medical device contract manufacturers in Australia are well-positioned to meet this demand by providing scalable and cost-effective production solutions that can adapt to the dynamic healthcare needs of an aging population.
Advancements in Manufacturing Technology
The Australian medical device contract manufacturing market is also fueled by continuous advancements in manufacturing technologies, which enhance the efficiency, precision, and cost-effectiveness of medical device production. For instance, the Australian government has recognized the importance of advanced manufacturing technologies, investing in initiatives that promote automation, 3D printing, and smart manufacturing. These technologies enable the creation of complex, custom-built devices at a fraction of the time and cost compared to traditional manufacturing methods. Contract manufacturers equipped with cutting-edge capabilities can provide high-quality, precision devices with faster time-to-market, meeting the increasingly tight timelines set by medical device developers. Furthermore, advancements in material science, including the use of biocompatible materials and more durable components, allow for the development of more effective, long-lasting devices, contributing to the overall growth of the sector.
Outsourcing and Cost-Effective Solutions
Outsourcing has become a strategic approach for medical device companies looking to optimize production processes while maintaining a focus on core competencies such as product development and marketing. By partnering with contract manufacturers, companies can reduce their overhead costs, avoid large capital investments in manufacturing infrastructure, and leverage the expertise of specialized partners. This trend is particularly strong in the Australian market, where medical device companies seek cost-effective solutions while ensuring compliance with stringent regulatory standards. Contract manufacturers in Australia are well-equipped to navigate the regulatory landscape, offering services such as testing, validation, and certification to meet the strict requirements of local and international markets. As the pressure to reduce healthcare costs intensifies, outsourcing manufacturing to experienced contract partners becomes an increasingly attractive option for medical device companies.
Market Trends
Integration of IoT and AI Technologies
One of the most prominent trends in the Australian medical device contract manufacturing market is the integration of Internet of Things (IoT) and Artificial Intelligence (AI) technologies into medical devices. The increasing demand for digital health solutions has led to the development of smart medical devices that can connect to the internet and transmit real-time data, allowing healthcare providers to remotely monitor patients and make timely medical decisions. For instance, the Australian government has recognized the importance of digital health solutions, investing in initiatives that promote IoT-enabled medical devices and AI-driven healthcare analytics. This shift towards more intelligent, connected devices enables more personalized and efficient patient care, offering significant advantages in managing chronic conditions and post-operative recovery. As healthcare becomes increasingly data-driven, manufacturers are compelled to adapt and innovate to stay competitive in this rapidly evolving landscape.
Adoption of Advanced Manufacturing Techniques
Another significant trend in the Australian medical device contract manufacturing market is the adoption of advanced manufacturing techniques, including 3D printing, robotic automation, and precision machining. These technologies allow for the production of complex medical devices with high accuracy and efficiency, which is particularly crucial for items requiring detailed customization or intricate designs, such as implants and prosthetics. 3D printing, in particular, enables the creation of custom-made devices tailored to individual patients, which is becoming increasingly important as demand for personalized medicine grows. Robotic automation streamlines production processes, reduces human error, and enhances scalability, enabling manufacturers to meet rising demand without compromising quality. These advancements not only lower production costs but also shorten time-to-market, giving manufacturers a competitive edge in an increasingly fast-paced industry. Additionally, these techniques allow for the efficient production of smaller batches of devices, catering to niche markets or specialized products.
Emphasis on Sustainability and Eco-Friendly Practices
Sustainability has become a key focus within the Australian medical device contract manufacturing sector. For instance, Australian medical device manufacturers are actively exploring opportunities in emerging markets, leveraging government trade agreements and incentives to expand their global footprint. With the increasing global emphasis on reducing carbon footprints and managing waste, manufacturers are adopting eco-friendly practices to align with both regulatory requirements and consumer demand for sustainable products. This trend includes using recyclable and biodegradable materials, reducing energy consumption during manufacturing processes, and minimizing waste through more efficient production techniques. Manufacturers are also seeking to implement circular economy principles, such as product take-back programs or reprocessing and repurposing medical devices. These practices not only help manufacturers comply with environmental regulations but also enhance their corporate social responsibility profiles, attracting both environmentally conscious consumers and healthcare organizations. As sustainability becomes a more significant part of the business model, medical device manufacturers are positioning themselves as responsible players in the industry, meeting the rising expectations of both regulatory bodies and end-users.
Expansion into Emerging Markets
As the demand for medical devices continues to rise globally, Australian medical device contract manufacturers are increasingly looking to expand into emerging markets in Asia, Latin America, and Africa. These regions are experiencing rapid urbanization and industrialization, which is contributing to an increase in healthcare infrastructure investments and the demand for medical devices. Additionally, many emerging markets are seeing a rise in chronic diseases, aging populations, and a growing middle class, all of which require advanced medical solutions. By targeting these high-growth regions, Australian manufacturers can diversify their customer base and capitalize on new revenue streams. Furthermore, expanding into emerging markets allows manufacturers to leverage cost advantages, take advantage of local government incentives, and overcome potential supply chain challenges. The global push for accessible and affordable healthcare is opening new avenues for growth, and Australian medical device contract manufacturers are well-positioned to capture these opportunities through strategic partnerships and market entry initiatives.
Market Challenges Analysis
Stringent Regulatory Compliance and Standards
One of the significant challenges facing the Australian medical device contract manufacturing sector is navigating stringent regulatory requirements. These regulations cover various stages of the product lifecycle, including design, development, testing, and post-market surveillance. For instance, the Australian Therapeutic Goods Administration (TGA) enforces strict regulations on medical device manufacturing, requiring adherence to ISO certifications and CE marking standards. For contract manufacturers, staying up-to-date with evolving regulatory frameworks can be resource-intensive and may delay time-to-market for new products. Furthermore, non-compliance can result in significant financial penalties and damage to brand reputation, making regulatory adherence a critical challenge for manufacturers seeking to expand their global reach.
Supply Chain Disruptions and Raw Material Shortages
Another challenge faced by the Australian medical device contract manufacturing industry is supply chain disruptions and raw material shortages. The global medical device sector relies on a variety of specialized materials, such as biocompatible polymers and metals, which can be subject to price volatility and supply chain bottlenecks. Disruptions, whether due to geopolitical issues, natural disasters, or the impact of global pandemics like COVID-19, can result in delayed shipments, increased costs, and difficulties in meeting production timelines. For contract manufacturers, managing these risks while maintaining high standards of quality and on-time delivery is an ongoing challenge. Furthermore, fluctuations in raw material prices can erode profit margins, particularly for manufacturers working with fixed-cost contracts. Ensuring a stable and resilient supply chain requires diversification of suppliers, investment in strategic partnerships, and enhanced forecasting capabilities to minimize the impact of these disruptions on production schedules.
Market Opportunities
The Australian medical device contract manufacturing market presents significant opportunities driven by the increasing demand for advanced healthcare solutions and a growing focus on cost-effective production. As healthcare providers seek more sophisticated medical devices to address an aging population and rising chronic disease rates, the need for specialized contract manufacturers becomes more pronounced. These manufacturers can leverage their expertise in high-quality, precision manufacturing to meet the growing demand for both high-volume and customized medical devices, ranging from diagnostics equipment to surgical instruments. Moreover, the shift toward personalized medicine, which requires patient-specific devices, further fuels demand for contract manufacturers capable of producing bespoke solutions. The expanding use of technologies such as 3D printing, automation, and AI-driven production systems creates additional opportunities to enhance manufacturing efficiency and speed up time-to-market, allowing Australian manufacturers to capture a larger share of the global market.
Another significant opportunity lies in the growing trend of outsourcing manufacturing by medical device companies, particularly as firms aim to reduce costs and focus on core competencies such as research and development. Australian contract manufacturers are well-positioned to cater to this demand, offering cost-effective and flexible production solutions while adhering to strict regulatory standards. Additionally, the global expansion of healthcare markets, particularly in emerging regions such as Asia and Africa, presents new avenues for Australian manufacturers to explore. By capitalizing on these international opportunities, local contract manufacturers can tap into fast-growing markets, leveraging Australia’s strong reputation for high-quality medical devices. As global healthcare infrastructure continues to improve and the demand for medical technology rises, Australian medical device contract manufacturers have a unique opportunity to expand their global footprint while contributing to advancements in healthcare.
Market Segmentation Analysis:
By Class:
The Australian medical device contract manufacturing market can be segmented by device classification into Class I, Class II, and Class III devices. Class I devices are low-risk products such as bandages, thermometers, and surgical instruments that generally require minimal regulatory control. These products are simpler to manufacture and involve fewer regulatory hurdles, offering opportunities for cost-efficient production. Class II devices, which include more complex devices like infusion pumps and diagnostic equipment, pose moderate risk and require more stringent regulatory oversight. Manufacturers involved in Class II device production must adhere to specific standards and certification processes, ensuring higher complexity in manufacturing and quality control. Class III devices, such as pacemakers and heart valves, represent high-risk products requiring the highest level of regulatory scrutiny and advanced manufacturing capabilities. Manufacturers of Class III devices face more stringent compliance and validation processes, which, while challenging, provide opportunities for contract manufacturers to leverage specialized expertise and deliver high-quality, life-critical products.
By Services:
The market for medical device contract manufacturing in Australia is also segmented by services, each catering to distinct manufacturing needs. Accessories manufacturing includes the production of supplementary components for medical devices, such as power adapters or connectors, which are crucial for the proper functioning of devices. Assembly manufacturing involves the integration of individual components into final, functioning devices, a critical service for manufacturers who need high levels of precision and efficiency. Component manufacturing focuses on producing individual parts, such as sensors or actuators, that form the building blocks of medical devices. Device manufacturing refers to the complete production of finished medical devices, ranging from diagnostics equipment to surgical tools, requiring advanced engineering and compliance with international standards. Packaging and labeling services are essential for ensuring medical devices are safely packaged and comply with regulatory requirements for distribution. Lastly, other services like testing, validation, and sterilization provide additional value to manufacturers seeking comprehensive solutions, further expanding the opportunities for contract manufacturers in the Australian medical device sector.
Segments:
Based on Class:
Class I
Class II
Class III
Based on Services:
Accessories Manufacturing
Assembly Manufacturing
Component Manufacturing
Device Manufacturing
Packaging and Labelling
Others
Based on End- Use:
Original Equipment Manufacturers (OEMs)
Pharmaceutical & Biopharmaceutical Companies
Others
Based on Therapeutic Area:
Cardiovascular Devices
Orthopedic Devices
Ophthalmic Devices
Diagnostic Devices
Respiratory Devices
Surgical Instruments
Dental
Others
Based on the Geography:
New South Wales
Victoria
Queensland
Western Australia (WA)
South Australia
Regional Analysis
New South Wales (NSW)
New South Wales (NSW) holds the largest market share, accounting for approximately 35% of the market. The state’s dominance can be attributed to its strong healthcare infrastructure, advanced research and development capabilities, and proximity to major medical device manufacturers and suppliers. Sydney, as a hub for innovation and technology, plays a key role in driving demand for contract manufacturing services. Additionally, NSW’s highly skilled workforce and favorable regulatory environment further position it as the leading region in the market.
Victoria
Victoria follows closely with a market share of around 30%. Known for its thriving medical technology and biotechnology industries, Victoria is home to a significant number of medical device companies and contract manufacturers. The state’s strong emphasis on healthcare innovation, coupled with institutions such as the University of Melbourne and Monash University, fosters a collaborative environment for the development of new medical technologies. Melbourne, in particular, serves as a central point for medical device research, attracting both domestic and international companies to the region. As a result, Victoria continues to experience robust demand for contract manufacturing services across various device categories.
Queensland
Queensland represents approximately 20% of the market share and is known for its growing presence in the medical device sector. The region benefits from a combination of government incentives and a focus on healthcare innovation, particularly in the fields of diagnostics and wearables. Brisbane, as the state’s capital, has seen increasing investment in medical device development, attracting new manufacturers and expanding the need for contract manufacturing services. Queensland’s strong healthcare ecosystem and increasing demand for more affordable medical technologies provide opportunities for manufacturers to scale and diversify their offerings.
Western Australia (WA) and South Australia
Western Australia (WA) and South Australia contribute to the remaining 15% of the market share, with WA accounting for 10% and South Australia around 5%. WA’s medical device manufacturing is centered around Perth, with a focus on specialized equipment for mining and healthcare sectors. South Australia, on the other hand, is home to Adelaide, a city with a growing presence in medical technology, particularly in areas like medical imaging and prosthetics. While these regions have smaller market shares compared to NSW, Victoria, and Queensland, their contributions are increasing as demand for medical device outsourcing services continues to grow, and as these regions invest more in healthcare technology development.
Key Player Analysis
ResMed
Cochlear Limited
Freudenberg Medical
Osmosis Medical
CSL Limited
Competitive Analysis
The competitive landscape of the Australia Medical Device Contract Manufacturing market is shaped by the presence of several established players who bring strong expertise, innovation, and global reach to the industry. Key players include ResMed, Cochlear Limited, Freudenberg Medical, Osmosis Medical, and CSL Limited. These companies maintain a competitive edge through extensive product portfolios, advanced manufacturing capabilities, and strategic collaborations within the healthcare ecosystem. These firms differentiate themselves through innovation, offering a wide range of manufacturing services such as device assembly, component production, and packaging tailored to the evolving needs of medical device companies. Many are increasingly adopting advanced technologies like automation, 3D printing, and smart manufacturing systems to enhance precision, scalability, and efficiency in production processes. To maintain a competitive edge, manufacturers are also investing heavily in research and development, building strategic partnerships with medical technology firms, and expanding their global reach. Their competitive strategies focus on ensuring timely delivery, high product quality, and compliance with international standards such as ISO 13485. As demand rises for complex and personalized medical devices, competition is expected to further intensify, with manufacturers striving to offer more integrated and value-added services across the device lifecycle.
Recent Developments
In February 2025, Jabil completed the acquisition of Pii, a contract development and manufacturing organization (CDMO) specializing in aseptic filling, lyophilization, and oral solid dose manufacturing.
In November 2024, Integer completed the sale of its non-medical Electrochem business for $50 million, making it a pure-play medical technology company and allowing it to redeploy capital into high-growth medtech markets.
In October 2024, At CPHI Milan 2024, Thermo Fisher launched its Accelerator Drug Development platform, a 360° CDMO and CRO offering. This service provides customizable manufacturing, clinical research, and supply chain solutions for small molecules, biologics, and cell and gene therapies, covering the full drug development lifecycle.
Market Concentration & Characteristics
The Australia Medical Device Contract Manufacturing market exhibits a moderate to high level of market concentration, with a mix of well-established manufacturers and a growing number of specialized firms. The market is characterized by a strong focus on precision, quality, and regulatory compliance, which are essential in meeting the stringent requirements of medical device production. Larger contract manufacturers typically dominate due to their ability to provide end-to-end solutions, advanced technological infrastructure, and long-standing relationships with global medtech companies. However, niche players are gaining traction by offering specialized services and greater flexibility. The industry operates in a highly regulated environment, fostering a culture of quality assurance and innovation. Market characteristics include a shift towards integrated manufacturing solutions, growing adoption of automation, and rising demand for customized, low-to-medium volume production. The market also benefits from Australia’s strong research ecosystem and skilled workforce, making it an attractive destination for medical device outsourcing.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The research report offers an in-depth analysis based on Class,Services, End-Use,Therapeutic Areaand Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Demand for contract manufacturing in Australia’s medical device sector will continue to grow due to increased outsourcing by OEMs.
Technological advancements will drive innovation and efficiency in manufacturing processes.
Regulatory support and streamlined approvals will encourage domestic production partnerships.
Rising healthcare needs and aging population will boost the requirement for complex medical devices.
Local manufacturers will expand capabilities to offer end-to-end solutions for global clients.
Investment in automation and digital health technologies will enhance production capacity and quality.
International collaborations will increase as Australian firms seek global market integration.
Sustainability and eco-friendly practices will become a priority across production processes.
Skilled workforce development will remain essential to support advanced manufacturing needs.
Government incentives and R&D funding will strengthen the sector’s global competitiveness.
CHAPTER NO. 1 : INTRODUCTION 19
1.1.1. Report Description 19 Purpose of the Report 19 USP & Key Offerings 19
1.1.2. Key Benefits for Stakeholders 19
1.1.3. Target Audience 20
1.1.4. Report Scope 20 CHAPTER NO. 2 : EXECUTIVE SUMMARY 21
2.1. Australia Medical Device Contract Manufacturing Market Snapshot 21
2.1.1. Australia Medical Device Contract Manufacturing Market, 2018 – 2032 (USD Million) 22 CHAPTER NO. 3 : AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET – INDUSTRY ANALYSIS 23
3.1. Introduction 23
3.2. Market Drivers 24
3.2.1. Strong Regulatory Framework Ensuring Safety and Quality Standards 24
3.2.2. Emergence of Advanced Technologies Enhancing Medical Device Manufacturing 25
3.3. Market Restraints 26
3.3.1. Complex and Lengthy Regulatory Processes Affecting Speed-to-Market 26
3.4. Market Opportunities 27
3.4.1. Market Opportunity Analysis 27
3.5. Porter’s Five Forces Analysis 28 CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 29
4.1. Company Market Share Analysis – 2024 29
4.1.1. Australia Medical Device Contract Manufacturing Market: Company Market Share, by Volume, 2024 29
4.1.2. Australia Medical Device Contract Manufacturing Market: Company Market Share, by Revenue, 2024 30
4.1.3. Australia Medical Device Contract Manufacturing Market: Top 6 Company Market Share, by Revenue, 2024 30
4.1.4. Australia Medical Device Contract Manufacturing Market: Top 3 Company Market Share, by Revenue, 2024 31
4.2. Australia Medical Device Contract Manufacturing Market Company Revenue Market Share, 2024 32
4.3. Company Assessment Metrics, 2024 33
4.3.1. Stars 33
4.3.2. Emerging Leaders 33
4.3.3. Pervasive Players 33
4.3.4. Participants 33
4.4. Start-ups /SMEs Assessment Metrics, 2024 33
4.4.1. Progressive Companies 33
4.4.2. Responsive Companies 33
4.4.3. Dynamic Companies 33
4.4.4. Starting Blocks 33
4.5. Strategic Developments 34
4.5.1. Acquisitions & Mergers 34 New Product Launch 34 Australia Expansion 34
4.6. Key Players Product Matrix 35 CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 36
5.1. PESTEL 36
5.1.1. Political Factors 36
5.1.2. Economic Factors 36
5.1.3. Social Factors 36
5.1.4. Technological Factors 36
5.1.5. Environmental Factors 36
5.1.6. Legal Factors 36
5.2. Adjacent Market Analysis 36 CHAPTER NO. 6 : AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET – BY CLASS SEGMENT ANALYSIS 37
6.1. Australia Medical Device Contract Manufacturing Market Overview, by Class Segment 37
6.1.1. Australia Medical Device Contract Manufacturing Market Revenue Share, By Class, 2023 & 2032 38
6.1.2. Australia Medical Device Contract Manufacturing Market Attractiveness Analysis, By Class 39
6.1.3. Incremental Revenue Growth Opportunity, by Class, 2024 – 2032 39
6.1.4. Australia Medical Device Contract Manufacturing Market Revenue, By Class, 2018, 2023, 2027 & 2032 40
6.2. Class I 41
6.3. Class II 42
6.4. Class III 43 CHAPTER NO. 7 : AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET – BY SERVICES SEGMENT ANALYSIS 44
7.1. Australia Medical Device Contract Manufacturing Market Overview, by Services Segment 44
7.1.1. Australia Medical Device Contract Manufacturing Market Revenue Share, By Services, 2023 & 2032 45
7.1.2. Australia Medical Device Contract Manufacturing Market Attractiveness Analysis, By Services 46
7.1.3. Incremental Revenue Growth Opportunity, by Services, 2024 – 2032 46
7.1.4. Australia Medical Device Contract Manufacturing Market Revenue, By Services, 2018, 2023, 2027 & 2032 47
7.2. Accessories Manufacturing 48
7.3. Assembly Manufacturing 49
7.4. Component Manufacturing 50
7.5. Device Manufacturing 51
7.6. Packaging and Labeling 52
7.7. Others 53 CHAPTER NO. 8 : AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET – BY END-USE SEGMENT ANALYSIS 54
8.1. Australia Medical Device Contract Manufacturing Market Overview, by End-use Segment 54
8.1.1. Australia Medical Device Contract Manufacturing Market Revenue Share, By End-use, 2023 & 2032 55
8.1.2. Australia Medical Device Contract Manufacturing Market Attractiveness Analysis, By End-use 56
8.1.3. Incremental Revenue Growth Opportunity, by End-use, 2024 – 2032 56
8.1.4. Australia Medical Device Contract Manufacturing Market Revenue, By End-use, 2018, 2023, 2027 & 2032 57
8.2. Original Equipment Manufacturers (OEMs) 58
8.3. Pharmaceutical & Biopharmaceutical Companies 59
8.4. Others 60 CHAPTER NO. 9 : AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET – BY THERAPEUTIC AREA SEGMENT ANALYSIS 61
9.1. Australia Medical Device Contract Manufacturing Market Overview, by Therapeutic Area Segment 61
9.1.1. Australia Medical Device Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032 62
9.1.2. Australia Medical Device Contract Manufacturing Market Attractiveness Analysis, By Therapeutic Area 63
9.1.3. Incremental Revenue Growth Opportunity, by Therapeutic Area, 2024 – 2032 63
9.1.4. Australia Medical Device Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032 64
9.2. Cardiovascular Devices 65
9.3. Orthopedic Devices 66
9.4. Ophthalmic Devices 67
9.5. Diagnostic Devices 68
9.6. Respiratory Devices 69
9.7. Surgical Instruments 70
9.8. Dental 71
9.9. Others 72 CHAPTER NO. 10 : AUSTRALIA MEDICAL DEVICE CONTRACT MANUFACTURING MARKET – AUSTRALIA ANALYSIS 73
10.1. Class 73
10.1.1. Australia Medical Device Contract Manufacturing Market Revenue, By Class, 2018 – 2023 (USD Million) 73
10.1.2. Australia Medical Device Contract Manufacturing Market Revenue, By Class, 2024 – 2032 (USD Million) 73
10.2. Services 74
10.2.1. Australia Medical Device Contract Manufacturing Market Revenue, By Services, 2018 – 2023 (USD Million) 74
10.2.2. Australia Medical Device Contract Manufacturing Market Revenue, By Services, 2024 – 2032 (USD Million) 74
10.3. End-use 75
10.3.1. Australia Medical Device Contract Manufacturing Market Revenue, By End-use, 2018 – 2023 (USD Million) 75
10.3.2. Australia Medical Device Contract Manufacturing Market Revenue, By End-use, 2024 – 2032 (USD Million) 75
10.4. Therapeutic Area 76
10.4.1. Australia Medical Device Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 76
10.4.2. Australia Medical Device Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 76 CHAPTER NO. 11 : COMPANY PROFILES 77
11.1. ResMed 77
11.1.1. Company Overview 77
11.1.2. Product Portfolio 77
11.1.3. Swot Analysis 77
11.1.4. Business Strategy 78
11.1.5. Financial Overview 78
11.2. Cochlear Limited 79
11.3. Freudenberg Medical 79
11.4. Osmosis Medical 79
11.5. CSL Limited 79
11.6. Company 6 79
11.7. Company 7 79
11.8. Company 8 79
11.9. Company 9 79
11.10. Company 10 79
11.11. Company 11 79
11.12. Company 12 79
11.13. Company 13 79
11.14. Company 14 79
List of Figures
FIG NO. 1. Australia Medical Device Contract Manufacturing Market Revenue, 2018 – 2032 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for Australia Medical Device Contract Manufacturing Market 28
FIG NO. 3. Company Share Analysis, 2024 29
FIG NO. 4. Company Share Analysis, 2024 30
FIG NO. 5. Company Share Analysis, 2024 30
FIG NO. 6. Company Share Analysis, 2024 31
FIG NO. 7. Australia Medical Device Contract Manufacturing Market – Company Revenue Market Share, 2024 32
FIG NO. 8. Australia Medical Device Contract Manufacturing Market Revenue Share, By Class, 2023 & 2032 38
FIG NO. 9. Market Attractiveness Analysis, By Class 39
FIG NO. 10. Incremental Revenue Growth Opportunity by Class, 2024 – 2032 39
FIG NO. 11. Australia Medical Device Contract Manufacturing Market Revenue, By Class, 2018, 2023, 2027 & 2032 40
FIG NO. 12. Australia Medical Device Contract Manufacturing Market for Class I, Revenue (USD Million) 2018 – 2032 41
FIG NO. 13. Australia Medical Device Contract Manufacturing Market for Class II, Revenue (USD Million) 2018 – 2032 42
FIG NO. 14. Australia Medical Device Contract Manufacturing Market for Class III, Revenue (USD Million) 2018 – 2032 43
FIG NO. 15. Australia Medical Device Contract Manufacturing Market Revenue Share, By Services, 2023 & 2032 45
FIG NO. 16. Market Attractiveness Analysis, By Services 46
FIG NO. 17. Incremental Revenue Growth Opportunity by Services, 2024 – 2032 46
FIG NO. 18. Australia Medical Device Contract Manufacturing Market Revenue, By Services, 2018, 2023, 2027 & 2032 47
FIG NO. 19. Australia Medical Device Contract Manufacturing Market for Accessories Manufacturing, Revenue (USD Million) 2018 – 2032 48
FIG NO. 20. Australia Medical Device Contract Manufacturing Market for Assembly Manufacturing, Revenue (USD Million) 2018 – 2032 49
FIG NO. 21. Australia Medical Device Contract Manufacturing Market for Component Manufacturing, Revenue (USD Million) 2018 – 2032 50
FIG NO. 22. Australia Medical Device Contract Manufacturing Market for Device Manufacturing, Revenue (USD Million) 2018 – 2032 51
FIG NO. 23. Australia Medical Device Contract Manufacturing Market for Packaging and Labeling, Revenue (USD Million) 2018 – 2032 52
FIG NO. 24. Australia Medical Device Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032 53
FIG NO. 25. Australia Medical Device Contract Manufacturing Market Revenue Share, By End-use, 2023 & 2032 55
FIG NO. 26. Market Attractiveness Analysis, By End-use 56
FIG NO. 27. Incremental Revenue Growth Opportunity by End-use, 2024 – 2032 56
FIG NO. 28. Australia Medical Device Contract Manufacturing Market Revenue, By End-use, 2018, 2023, 2027 & 2032 57
FIG NO. 29. Australia Medical Device Contract Manufacturing Market for Original Equipment Manufacturers (OEMs), Revenue (USD Million) 2018 – 2032 58
FIG NO. 30. Australia Medical Device Contract Manufacturing Market for Pharmaceutical & Biopharmaceutical Companies, Revenue (USD Million) 2018 – 2032 59
FIG NO. 31. Australia Medical Device Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032 60
FIG NO. 32. Australia Medical Device Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032 62
FIG NO. 33. Market Attractiveness Analysis, By Therapeutic Area 63
FIG NO. 34. Incremental Revenue Growth Opportunity by Therapeutic Area, 2024 – 2032 63
FIG NO. 35. Australia Medical Device Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032 64
FIG NO. 36. Australia Medical Device Contract Manufacturing Market for Cardiovascular Devices, Revenue (USD Million) 2018 – 2032 65
FIG NO. 37. Australia Medical Device Contract Manufacturing Market for Orthopedic Devices, Revenue (USD Million) 2018 – 2032 66
FIG NO. 38. Australia Medical Device Contract Manufacturing Market for Ophthalmic Devices, Revenue (USD Million) 2018 – 2032 67
FIG NO. 39. Australia Medical Device Contract Manufacturing Market for Diagnostic Devices, Revenue (USD Million) 2018 – 2032 68
FIG NO. 40. Australia Medical Device Contract Manufacturing Market for Respiratory Devices, Revenue (USD Million) 2018 – 2032 69
FIG NO. 41. Australia Medical Device Contract Manufacturing Market for Surgical Instruments, Revenue (USD Million) 2018 – 2032 70
FIG NO. 42. Australia Medical Device Contract Manufacturing Market for Dental, Revenue (USD Million) 2018 – 2032 71
FIG NO. 43. Australia Medical Device Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032 72
List of Tables
TABLE NO. 1. : Australia Medical Device Contract Manufacturing Market: Snapshot 21
TABLE NO. 2. : Drivers for the Australia Medical Device Contract Manufacturing Market: Impact Analysis 24
TABLE NO. 3. : Restraints for the Australia Medical Device Contract Manufacturing Market: Impact Analysis 26
TABLE NO. 4. : Australia Medical Device Contract Manufacturing Market Revenue, By Class, 2018 – 2023 (USD Million) 73
TABLE NO. 5. : Australia Medical Device Contract Manufacturing Market Revenue, By Class, 2024 – 2032 (USD Million) 73
TABLE NO. 6. : Australia Medical Device Contract Manufacturing Market Revenue, By Services, 2018 – 2023 (USD Million) 74
TABLE NO. 7. : Australia Medical Device Contract Manufacturing Market Revenue, By Services, 2024 – 2032 (USD Million) 74
TABLE NO. 8. : Australia Medical Device Contract Manufacturing Market Revenue, By End-use, 2018 – 2023 (USD Million) 75
TABLE NO. 9. : Australia Medical Device Contract Manufacturing Market Revenue, By End-use, 2024 – 2032 (USD Million) 75
TABLE NO. 10. : Australia Medical Device Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 76
TABLE NO. 11. : Australia Medical Device Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 76
Frequently Asked Questions:
What is the current size of the Australia Medical Device Contract Manufacturing?
The market was valued at USD 1,287.68 million in 2024.
What factors are driving the growth of the Australia Medical Device Contract Manufacturing?
Growth is driven by rising demand for advanced medical devices, an aging population, technological innovation, and increased outsourcing.
What are the key segments within the Australia Medical Device Contract Manufacturing?
Key segments include Class I–III devices, services like device and component manufacturing, and therapeutic areas such as cardiovascular and diagnostics.
What are some challenges faced by the Australia Medical Device Contract Manufacturing?
Challenges include stringent regulatory compliance, raw material shortages, and global supply chain disruptions.
Who are the major players in the Australia Medical Device Contract Manufacturing?
Major players include ResMed, Cochlear Limited, Freudenberg Medical, Osmosis Medical, and CSL Limited.
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.
